Clinical Oncology
Volume 20, Issue 3 , Pages 221-226 , April 2008

Oesophagectomy after Definitive Chemoradiation in Patients with Locally Advanced Oesophageal Cancer

  • S. Borghesi
    • ,
  • M.A. Hawkins
    • ,
  • D. Tait

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: D. Tait, Department of Clinical Oncology, The Royal Marsden Foundation NHS Trust, Downs Road, Surrey SM2 5PT, Sutton, UK. Tel: +44-02086613365; Fax: +44-02086613160.

Received 25 June 2007 ,Revised 18 November 2007 ,Accepted 6 December 2007.

References 

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108
  2. Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the oesophagus: a meta-analysis. Ann Thorac Surg. 2001;72(1):306–313
  3. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus. N Engl J Med. 1992;326(24):1593–1598
  4. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced oesophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281(17):1623–1627
  5. Al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with oesophageal cancer: an intergroup study. J Clin Oncol. 1997;15(1):277–284
  6. Urschel JD, Sellke FW. Complications of salvage oesophagectomy. Med Sci Monit. 2003;9(7):RA173–RA180
  7. Urschel JD, Ashiku S, Thurer R, Sellke FW. Salvage or planned oesophagectomy after chemoradiation therapy for locally advanced oesophageal cancer – a review. Dis Oesophagus. 2003;16(2):60–65
  8. Murakami M, Kuroda Y, Takeda H, et al. Case report of 14-year survival after radiotherapy for clinical T3 oesophageal carcinoma, with local recurrence finally rescued by surgery. Radiat Med. 1999;17(6):459–462
  9. In:  Ries LAG,  Eisner MP,  Kosary C, et al. editor. SEER cancer statistic review, 1973–1999. Bethesda: National Cancer Institute; 2002;
  10. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for oesophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20(5):1167–1174
  11. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in oesophageal cancer. Hepatogastroenterology. 1994;41:391–393
  12. Burmeister BH, Smithers BM, Fitzgerald L, et al. A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the oesophagus. Prog Proc Am Soc Clin Oncol. 2002;21:130a
  13. Law S, Kwong D, Tung H, et al. Preoperative chemoradiation for squamous cell oesophageal cancer: a prospective randomized trial. Can J Gastroenterol. 1998;12(Suppl B):56B
  14. Bosset J-F, Gignoux M, Triboulet J-P, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the oesophagus. N Engl J Med. 1997;337:161–167
  15. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with loco-regional oesophageal carcinoma. J Clin Oncol. 2001;19:305–313
  16. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable oesophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy: the second Scandinavian trial in oesophageal carcinoma. World J Surg. 1992;16:1104–1110
  17. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the oesophagus. J Clin Oncol. 2005;23(10):2310–2317
  18. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the oesophagus. Cancer. 1994;73:1179–1184
  19. Swisher SG, Wynn P, Putnam JB, et al. Salvage oesophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg. 2002;123(1):175–183
  20. Tomimaru Y, Yano M, Takachi K, et al. Factors affecting the prognosis of patients with oesophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol. 2006;93(5):422–428
  21. Meunier B, Raoul J, Le Prise E, Lakehal M, Launois B. Salvage oesophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the oesophagus. Dig Surg. 1998;15(3):224–226
  22. Muro K, Najima M, Hamaguchi T, et al. Definitive chemoradiotherapy followed by salvage therapy for loco-regional failure might be a standard treatment option for stages I–III oesophageal squamous cell carcinoma. J Clin Oncol. 2005;23(16S):4069;[Part I of II (June 1 Supplement)]
  23. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with oesophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer. 2002;95(7):1434–1443
  24. Nakamura T, Hayashi K, Ota M, et al. Salvage oesophagectomy after definitive chemotherapy and radiotherapy for advanced oesophageal cancer. Am J Surg. 2004;188(3):261–266
  25. Gotohda N, Nishimura M, Yoshida J, Nagai K, Boku N, Ohtsu A. Salvage operation for oesophageal cancer after radical chemoradiotherapy. Kyobu Geka. 2002;55(9):743–746[discussion 746–749]
  26. Bonnetain F, Bouche O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic oesophageal cancer. Ann Oncol. 2006;17(5):827–834
  27. Stahl M, Kataja VV, Oliveira J. ESMO Guidelines Task Force. ESMO Minimal Clinical Recommendations for diagnosis, treatment and follow-up of oesophageal cancer. Ann Oncol. 2005;16(Suppl 1):i26–i27
  28. Triboulet JP, Amrouni H, Guillem P, Vandenhaute B, Lecomte-Houcke M, Adenis A. Long term results of oesophageal epidermoid cancers in complete remission after preoperative chemo-radiotherapy. Ann Chir. 1998;52(6):503–508
  29. Shaukat A, Mortazavi A, Demmy T, et al. Should preoperative, post-chemoradiotherapy endoscopy be routine for oesophageal cancer patients?. Dis Oesophagus. 2004;17(2):129–135
  30. Jones DR, Detterbeck FC, Egan TM, Parker LA, Bernard SA, Tepper JE. Induction chemoradiotherapy followed by oesophagectomy in patients with carcinoma of the oesophagus. Ann Thorac Surg. 1997;64(1):185–191
  31. Lim JT, Truong PT, Berthelet E, et al. Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for oesophageal cancer. Int J Radiat Oncol Biol Phys. 2003;57(5):1328–1335
  32. Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of oesophageal cancer after neoadjuvant chemoradiotherapy. Am Surg. 2000;66(9):827–831
  33. Rice TW, Boyce GA, Sivak MV, Adelstein DJ, Kirby TJ. Oesophageal carcinoma: oesophageal ultrasound assessment of preoperative chemotherapy. Ann Thorac Surg. 1992;53(6):972–977
  34. Chak A, Canto MI, Cooper GS, et al. Endosonographic assessment of multimodality therapy predicts survival of oesophageal carcinoma patients. Cancer. 2000;88(8):1788–1795
  35. Westerterp M, Van Westreenen HL, Reitsma JB, et al. Oesophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy systematic review. Radiology. 2005;236(3):841–851
  36. Flamen P, Van Cutsem E, Lerut A, et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol. 2002;13(3):361–368
  37. Munden RA, Macapinlac HA, Erasmus JJ. Oesophageal cancer: the role of integrated CT-PET in initial staging and response assessment after preoperative therapy. J Thorac Imaging. 2006;21(2):137–145

PII: S0936-6555(07)00892-8

doi: 10.1016/j.clon.2007.12.001

Clinical Oncology
Volume 20, Issue 3 , Pages 221-226 , April 2008

Article Tools